CCA
REPL icon

Catalyst Capital Advisors’s Replimune Group REPL Stock Holding History

Catalyst Capital Advisors’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-375
Closed -$6K – 475
2018
Q3 		$6K Buy
+375
New +$6.57K ﹤0.01% 388

Other funds holding REPL

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Catalyst Capital Advisors's REPL Position: Q4 2018 in Review

Catalyst Capital Advisors sold out of Replimune Group (REPL) in Q4 2018, closing a stake of 375 shares — an estimated $6K sold.

Catalyst Capital Advisors first reported a position in REPL in Q3 2018 and held it in 1 quarter. The position peaked at $6K in Q3 2018. 51 funds tracked by Wall St. Rank hold REPL as of Q4 2018.

  • Catalyst Capital Advisors reported no remaining Replimune Group position as of Q4 2018 after selling out during the quarter.
  • Catalyst Capital Advisors sold 375 Replimune Group shares in Q4 2018, an estimated $6K.
  • Catalyst Capital Advisors first reported a position in Replimune Group in Q3 2018 and held it in 1 quarter.
  • Catalyst Capital Advisors's Replimune Group position peaked at $6K in Q3 2018.
  • 51 funds tracked by Wall St. Rank held Replimune Group as of Q4 2018.

Based on Catalyst Capital Advisors's 13F filing for Q4 2018, filed 7 Feb 2019.